Medline Sterile Elastic Esmark Bandage Recall: Non-sterile Risk
Medline recalls sterile elastic bandages that may not have been properly sterilized, posing a non-sterile risk. Affected items include specific model numbers and production lots.
Lower-risk recall
Product did not undergo correct sterilization procedures and may potentially be non-sterile.
Contact the company
What happened, in plain English
Medline is recalling sterile elastic bandages that may not have been properly sterilized. Using non-sterile bandages could lead to infections or other health risks, especially in medical settings. Read more at govinfonow.com/recall/73397-medline-sterile-elastic-esmark-bandage-recall-non-sterile-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/73397-medline-sterile-elastic-esmark-bandage-recall-non-sterile-risk · Updated September 20, 2026 · FDA enforcement record: FDA #Z-0295-2018
Cite this page
“Medline Sterile Elastic Esmark Bandage Recall: Non-sterile Risk.” GovInfoNow, updated September 20, 2026. https://govinfonow.com/recall/73397-medline-sterile-elastic-esmark-bandage-recall-non-sterile-risk. Based on FDA recall #Z-0295-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0295-2018%22&limit=1).
Why it’s dangerous
The bandages may not have undergone correct sterilization, meaning they could be non-sterile. This poses a risk of infection or contamination if used in medical procedures.
Who’s affected
Healthcare workers and patients using the bandages for medical purposes are most at risk. The recall affects specific model numbers and production lots.
How to tell if you have this one
Check for model number DYNJ05914 and production lots 17GB3101, 172B2025, 17FB9612, or 17QB8614. The bandages come in individually packaged Tyvek pouches inside corrugate cases with 20 bandages per case.
- Brand
Medline- Category
Medical device
What to do — step by step
Check Product Details
Identify the model number and production lots listed in the recall notice.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 30 states.
FDA distribution: “Worldwide Distribution - US Nationwide in the states of AK, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, NC, NH, NJ, NY, OH, OK, OR, PA, TN, TX, WA and the countries of Canada, Saudi Arabia, and Netherlands.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Washington.
Recall timeline
FDA terminated this recall 2.8 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-0295-2018 (July 18, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0295-2018 to see it in context.
- Plain-language summary written by qwen3:4b on September 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.